AbbVie | Fremdkapital



Loan Capital Veränderung Datum
AbbVie USD 60.34B 1.83B 2024-12
Abbott USD 12.74B 111M 2025-03
ALKERMES USD 0 0 2025-03
Amgen USD 54.01B 2.54B 2025-03
AstraZeneca USD 27.89B 154M 2025-03
Biogen USD 4.55B 1.4M 2024-12
BioMarin Pharmaceutical USD 595.65M 244K 2025-03
Bristol-Myers Squibb USD 46.16B 1.45B 2025-03
Eisai JPY 99.82B 9M 2024-12
Eli Lilly USD 34.5B 5.97B 2025-03
Gilead Sciences USD 24.9B 3.46B 2024-12
GlaxoSmithKline GBP 16.47B 1.84B 2025-03
J&J USD 38.36B 7.7B 2025-03
Medtronic USD 23.99B 622M 2025-01
Merck USD 34.46B 520M 2024-12
Neurocrine Biosciences USD 0 0 2024-12
Novartis USD 22.93B 2.41B 2024-12
Pacira USD 383.54M 2.35M 2024-12
Perrigo USD 3.58B 730.9M 2024-12
Pfizer USD 57.4B 597M 2024-12
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Roche Holding CHF 32.1B 1.94B 2024-12
Sanofi 13.41B 1.62B 2025-03
UCB EUR 2.82B 166M 2024-12
Ultragenyx Pharmaceutical USD 0 0 2024-12
United Therapeutics USD 0 0 2025-03
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12
Zoetis USD 5.22B 1.35B 2024-12



AbbVie Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.